This article was originally published in The Tan Sheet
F-D-C Reports' longest-serving employee with 44 years of service to the publisher of "The Tan Sheet" passed away Dec. 29 at age 79. For over four decades, Picken was the voice of F-D-C to many subscribers and libraries, handling subscription requests and delivery issues. Contributions may be made to the Casey House, 6001 Muncaster Mill Rd., Rockville, Md. 20855 or to the American Cancer Society, 1875 Connecticut Ave., NW, Washington, D.C. 20009...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”